2017
DOI: 10.1101/196410
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A Non-Synonymous SHARPIN Variant is Associated with Limbic Degeneration and Family History of Alzheimer’s Disease

Abstract: Mapping the spatiotemporal dynamics of brain atrophy in the Alzheimer's disease (AD) aids in discovering vulnerable brain networks. Various MRI-derived measures including hippocampal volume loss are commonly used as imaging biomarkers of AD progression. Multivariate methods such as independent component analysis (ICA) have recently shown promise in revealing more complex patterns of brain atrophy.Here, we aimed to extract a data-driven signature of brain atrophy in AD and its heralding risk factor, the mild… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 33 publications
(36 reference statements)
0
1
0
Order By: Relevance
“…CT, one of the most sensitive imaging biomarkers of structural brain atrophy in AD, was selected as an endophenotype and was found to be strongly correlated with 4 genes (B4GALNT1, RAB44, LOC101927583, and SLC26A10) related to protein degradation, neuronal deletion, and apoptosis (25,26). Another GWAS study showed that the medial temporal circuit (MTC) could be used as another imaging phenotype and that the SNP rs34173062 in the SHARPIN gene had a genetic modifying effect on MTC atrophy (27). Recently, it was demonstrated that the SNP rs661526 modulated the expression of NFIA in the substantia nigra and the frontal cortex (FCTX), and the SNP rs10109716 modulated the expression of ST18 in the thalamus, which were significantly associated with increased CT in the left parahippocampal gyrus and left inferior frontal gyrus, respectively (28).…”
Section: Introductionmentioning
confidence: 99%
“…CT, one of the most sensitive imaging biomarkers of structural brain atrophy in AD, was selected as an endophenotype and was found to be strongly correlated with 4 genes (B4GALNT1, RAB44, LOC101927583, and SLC26A10) related to protein degradation, neuronal deletion, and apoptosis (25,26). Another GWAS study showed that the medial temporal circuit (MTC) could be used as another imaging phenotype and that the SNP rs34173062 in the SHARPIN gene had a genetic modifying effect on MTC atrophy (27). Recently, it was demonstrated that the SNP rs661526 modulated the expression of NFIA in the substantia nigra and the frontal cortex (FCTX), and the SNP rs10109716 modulated the expression of ST18 in the thalamus, which were significantly associated with increased CT in the left parahippocampal gyrus and left inferior frontal gyrus, respectively (28).…”
Section: Introductionmentioning
confidence: 99%